taliglucerase alfa (Elelyso)

Introduction

Indiactions:

• FDA-approved for treatment of Gaucher disease type 1

Dosage

• intravenous infusion every 2 weeks

Mechanism of action

• recombinant glucocerebrosidase

Notes

• first plant-made pharmaceutical to win approval by the FDA

More general terms

• recombinant protein; chimer
• metabolic agent (metabolic modifier)